NCT03014297 2019-08-08Fosbretabulin With Everolimus in Neuroendocrine Tumors With ProgressionUniversity of KentuckyPhase 1 Terminated17 enrolled
NCT02279602 2018-04-17Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 StudyMateon TherapeuticsPhase 2 Completed7 enrolled